INSOL Anti-Human IFN-γ Synthetic Antibody
| Product Name | INSOL Anti-Human IFN-γ Synthetic Antibody |
|---|
Product Information
Discover our new antibody for the detection of human
Interferon-γ!
First release in our incoming range of recombinant, synthetic antibodies targeting human cytokines.
Our synthetic antibodies are developed at the KRIBB, Korea, by linking Fab fragments with proprietary linkers, yielding antibodies with high affinity and stability.
They are
expressed in E. coli and highly purified to display performances similar
to that of natural antibodies.
Catalog Number | RP04-100ug |
Product description | Recombinant synthetic antibody targeting human IFN-γ, obtained by linking Fab fragments with a proprietary linker. Theoretical molecular weight: 106 kDa; pI: 7.16. Does not contain any affinity tags. |
Target | human IFN-γ |
Host | Produced as a recombinant protein from E. coli |
Clonality | Monoclonal |
Purification | >90% (SDS-PAGE, reducing conditions) |
Concentration | 0.5 mg/mL |
Buffer | PBS pH 7.4, 150 mM NaCl |
Dilution and storage | Dilute in PBS pH 7.4, 150 mM NaCl supplemented with 0.1% BSA. Aliquots and store at 4°C for less than a week. Store at -20°C for longer term storage. Avoid freeze-thaw cycles. |
Applications | · ELISA, western blot or Immunolabelling. This antibody will react with anti-Human-CH1 secondary antibodies. · Neutralization assays. For each assay, optimal dilution conditions should be determined by the researcher. |
